One example of the kind of work The BioChain Advisory does: helping organisations work out whether their systems can actually prove what they claim, before a regulator, investor, customer or incident forces the question. Here is how that played out.
A UK-based company was preparing to establish operations in one or more European Union jurisdictions. Its legal advisers could explain the regulatory framework and identify the relevant obligations. What the organisation also needed was an understanding of how those obligations interacted with its actual technical environment.
The company operated across a mixture of cloud providers, SaaS platforms, laboratory systems, customer databases, analytics services and outsourced processors. Different categories of information were stored in different countries. Some third parties processed data in additional jurisdictions. Backups followed different geographic rules from production systems. Access was provided to teams working from several countries.
The legal position was clear in principle. The practical evidence was fragmented.
We ran a Regulatory & Cross-Border Readiness Review to map the operational reality: where relevant information was created, stored and processed; which internal and external organisations interacted with it; how information moved between jurisdictions; which processors formed part of the chain; what records existed to demonstrate access and processing; and how retention, deletion, backup and recovery operated in practice.
The review also tested whether the organisation’s own claims about data handling were supported by the systems themselves. Where a policy stated that certain information was retained for a defined period, could the organisation demonstrate that the underlying systems actually enforced that? Where a supplier was described as processing data only in a particular region, was there technical evidence supporting that position? Where records had to be deleted, could the organisation demonstrate what happened to copies held in backups or downstream systems?
The BioChain Advisory did not provide legal interpretation or replace specialist counsel. Its role was to build the organisation a technically accurate map of the systems, evidence and workflows to which that legal advice needed to be applied.
Before entering a new jurisdiction, does the organisation’s technical reality actually match what its policies claim?
The result gave legal, compliance and technical teams a common working picture, letting them focus on the places where regulation and operational reality were most likely to diverge. Fixing a technical evidence gap before expansion proved far easier than explaining it after a customer, regulator or partner raised the question.
No. The BioChain is not a law firm. This review maps the technical and evidential reality your legal advisers need in order to give you accurate advice.
An agreement describes what should happen. This review tests whether the systems and evidence actually support what the agreement claims — a gap that often exists even with solid paperwork.
Ashley Morgan, who holds a Master of Laws in International and European Law, working alongside the technical team — so the legal framing and the technical mapping happen together, not as two separate handoffs.
Yes. Where operations span several member states, the review maps the same evidence chain against each jurisdiction’s specific requirements rather than treating the EU as a single block.
The BioChain Advisory helps organisations understand how evidence actually moves through their existing systems, independent of whether they ever deploy The BioChain platform itself. Engagements typically take one of two forms: a Data Integrity Audit, tracing representative evidence chains from source to conclusion to establish what can genuinely be demonstrated, or a Regulatory & Cross-Border Readiness Review, examining whether an organisation's systems and records can support the claims a new jurisdiction or regulation requires.